Squarepoint
BIOR

Squarepoint’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

Squarepoint’s Portfolio BIOR Stock Details BIOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-64
Closed -$19K – 3596
2022
Q1 		$19K Sell
64
-82
-56% -$31.1K ﹤0.01% 2718
2021
Q4 		$76K Buy
+146
New +$105K ﹤0.01% 2976
2021
Q3 		– Sell
-81
Closed -$72K – 3654
2021
Q2 		$72K Buy
+81
New +$61.9K ﹤0.01% 3067
2020
Q4 		– Sell
-59
Closed -$133K – 3381
2020
Q3 		$133K Buy
+59
New +$133K ﹤0.01% 2220

Other funds holding BIOR

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Squarepoint's BIOR Position: Q2 2022 in Review

Squarepoint sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q2 2022, closing a stake of 64 shares — an estimated $19K sold.

Squarepoint first reported a position in BIOR in Q3 2020 and held it in 4 quarters. The position peaked at $133K in Q3 2020. 46 funds tracked by Wall St. Rank hold BIOR as of Q2 2022.

  • Squarepoint reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Squarepoint sold 64 Biora Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $19K.
  • Squarepoint first reported a position in Biora Therapeutics, Inc. Common Stock in Q3 2020 and held it in 4 quarters.
  • Squarepoint's Biora Therapeutics, Inc. Common Stock position peaked at $133K in Q3 2020.
  • 46 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q2 2022.

Based on Squarepoint's 13F filing for Q2 2022, filed 15 Aug 2022.